First of all: screening is not diagnosis.
The first-trimester ultrasound is, above all, an examination of tracking. In other words: he It doesn't give a diagnosis.. He estimates probabilities based on very sensitive measurements, obtained within a specific window of gestation.
If there are changes to any of these measures — such as nuchal translucency, the nasal bone, the ductus venosus flow or a tricuspid valve regurgitation The system calculates a higher risk of certain genetic syndromes.
But increased risk doesn't mean certainty. It means we need to investigate further.
What could interfere with the exam?
That's a valid question, and one I hear frequently in my office.
Some factors can indeed make it difficult to conduct the exam ideally. For example:
- Unfavorable fetal position
- Excessive fetal movement
- Very full maternal bladder
- Presence of intestinal gas
- The gestational window itself is very much at the limit.
These factors may require more time to complete, greater technical experience from the professional, and, in some cases, need to repeat the exam at a more appropriate time.
In my practice, it's common to repeat an ultrasound if conditions don't allow for reliable image acquisition. This is part of good practice.
What if the risk is considered too high?
When the calculation indicates a increased risk, The course of action depends on the level of risk and the characteristics of the case.
- To intermediate risks (between 1:50 and 1:250), It is recommended to do the NIPT., a blood test that analyzes circulating cell-free fetal DNA and can greatly reduce uncertainty, with a very high negative predictive value.
- To very high risks (above 1:50), especially with a increased nuchal translucency (above 3.5mm), It is recommended to consider diagnostic tests., like amniocentesis or chorionic villus sampling — because there is a greater chance of atypical genetic syndromes or diseases that can only be detected with a complete karyotype, array, or exome.
Furthermore, it is worth remembering that the NIPT is not a substitute for invasive testing. In these more serious cases, it only analyzes a limited group of syndromes.
Talking about risk is delicate but necessary.
Communicating a result that can change the course of a pregnancy is not simple. There is an ethical, technical, and human consideration in every word we use.
To say that a test showed an increased risk. It's not about being pessimistic.. It's about being transparent. It's about acknowledging the possibility and, at the same time, indicating the next steps with clarity and serenity.
It's common for parents to want to hear: "But doctor, is there a chance everything is alright?" And yes, often there is. Most cases of increased risk end with positive outcomes. But it's also our responsibility. do not minimize, do not omit and offer the necessary support (including emotional support) to cope with the period of uncertainty.
The role of fetal medicine is to guide, not to pronounce judgment.
As a specialist in fetal medicine, I am here to guide the couple based on science, clinical experience, and respectful listening. We know that every word matters. We know that waiting for a new test can be distressing.
And that is precisely why we strive to provide this support with clarity and care.
If you are experiencing uncertainty after your first-trimester ultrasound, seek out a professional who will listen to you, explain things to you, and walk alongside you.
Because the test can indicate a risk.
But we are the ones who help to face this risk. Together.



